News

ALS is a progressive and fatal neurological disorder with no known cure. A new clinic offering treatment raises alarms about ...
ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to discovery and development of ...
The ALS Association has announced the eight winners two new Hoffman award programs designed to improve access to ...
$2.4 million private financing plus an additional $6.8 million of proceeds due to exercise of warrants and $0.8 million from ...
The city of Covington is mourning the unexpected passing of Mayor Lance Carson, who died Saturday after a courageous battle with amyotrophic lateral sclerosis.
The device works by connecting a person’s nervous system to devices that can interpret their brain activity, allowing them to ...
Biogen said it intends to invest an additional $2 billion to expand operations at its largest manufacturing facilities within North Carolina’s Research Triangle Park (RTP).
Neuralink achieved two brain transplants in a day, targeting 20 by year-end. CEO Elon Musk envisions healing paralysis and ...
Researchers discovered that people carrying the APOE ε4 gene variant share a unique immune-related protein signature across ...
Texas lawmakers are revisiting a bill that aims to regulate hemp-derived consumable products, including THC. Here's what you need to know.
Amylyx is a high-risk biotech targeting rare diseases with strong cash reserves. Key trials soon may drive a 40% stock upside.